Healthcare AI startup Heidi Health just closed a $65 million Series B led by billionaire Steve Cohen's Point72, marking one of the largest funding rounds in the medical scribe space this year. The round comes as the company claims to have saved doctors over 18 million hours across 70 million patient visits in just 18 months since launch.
The healthcare AI revolution just got a major injection of capital. Heidi Health, the medical scribe startup founded by trauma surgeon Dr. Tom Kelly, landed a $65 million Series B from Steve Cohen's Point72 - and it's easy to see why investors are betting big on automating healthcare's most tedious tasks.
Dr. Kelly's pitch is simple but powerful: doctors are drowning in paperwork, and AI can throw them a lifeline. "We wanted to build an AI care partner that would stand alongside clinicians and take care of the admin so that individual providers, like me, can feel empowered to deliver the care which we dedicated our lives to," Kelly told TechCrunch.
The numbers tell the story of a company hitting serious scale. Since launching products in early 2024, Heidi Health claims to have returned "18 million hours to frontline healthcare providers from more than 70 million patient visits in 116 countries." That's the kind of traction that gets legendary investors like Cohen - who built a $30 billion hedge fund empire - to write big checks.
Point72's enthusiasm stems from what they saw under the hood. "They had seen all the scribes before," Dr. Kelly explained. "They'd never seen product adoption and usage metrics like they'd seen in Heidi. They also loved that we were obsessed about the end user experience, because they saw most of our competitors were just doing top-down sales."
The timing couldn't be better. Healthcare systems worldwide are grappling with physician burnout, with administrative tasks eating up to 40% of doctors' time. Heidi Health's AI medical scribe tackles the grunt work - transcribing notes, generating patient summaries, and tracking tasks so doctors can ditch their sticky note systems.
But Heidi Health isn't just another transcription tool. The company takes a model-agnostic approach, building its own AI while also leveraging models like Google's Gemini. "This model agnostic approach means that we can optimize our accuracy, latency, and cost," Kelly noted. It's a smart hedge against the rapidly evolving AI landscape.
The fresh funding comes with some serious firepower joining the team. Dr. Simon Kos, Microsoft's former Chief Medical Officer, is coming aboard, along with Plaid's head of revenue Paul Williamson. That's the kind of enterprise software and healthcare expertise that could accelerate Heidi Health's path to becoming the dominant platform in medical AI.
The competitive landscape is heating up fast. Heidi Health faces established players like DeepScribe, Ambiance Healthcare, and Abridge, all racing to capture the massive medical scribe market. But Heidi Health's freemium model and focus on user experience seem to be paying dividends - the company now works with over 2 million clinicians weekly.
What sets this round apart is the global vision. While most healthcare AI discussions focus on developed markets, Dr. Kelly sees Heidi Health democratizing healthcare capacity worldwide. "Imagine a world where any healthcare provider in the world can use Heidi to increase their clinical capacity, where they can practice in a war zone, or a refugee camp, or a region hit by climate change," he said.
The company also unveiled a new AI agent that automatically calls patients on behalf of doctors - a natural evolution that could further reduce administrative burden. It's exactly the kind of feature that demonstrates how AI can handle increasingly complex healthcare workflows.
With $96.6 million raised to date from investors including Goodwater Capital, Headline, Blackbird VC, and LG Technology Ventures, Heidi Health has the runway to execute on its ambitious vision of "doubling the world's healthcare capacity."
The Series B funds will fuel product development as the company looks to expand its AI capabilities. Given the explosive adoption metrics and Point72's backing, Heidi Health is positioning itself as the infrastructure layer for AI-powered healthcare - a massive opportunity in a market ripe for automation.
Heidi Health's massive Series B signals that healthcare AI has moved from experimental to essential. With Point72's backing and explosive user adoption, the company is well-positioned to capture the multi-billion dollar opportunity in medical automation. As healthcare systems worldwide face mounting pressure to do more with less, AI-powered administrative tools like Heidi's aren't just nice to have - they're becoming critical infrastructure for modern medicine.
